Is a Functional Cure Possible in Multiple Myeloma Therapy? | CancerNetwork

News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Trending on CancerNetwork

Yoga Could Alter Cancer-Related Fatigue Levels Across Solid Tumors

112 First-Line (1L) Datopotamab Deruxtecan (Dato-DXd) vs Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (mTNBC) for Whom Immunotherapy Was Not an Option: Primary Results From the Randomized, Phase 3 TROPION-Breast02 Trial

Moving Beyond R-CHOP: The Future of Upfront Precision Oncology in Lymphoma

Moving Bispecifics and Prophylaxis to Outpatient Multiple Myeloma Care

111 The Aurora Kinase A Inhibitor Alisertib Alone or in Combination With Endocrine Therapy for Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2–) Metastatic Breast Cancer (MBC)